Optimal warfarin management for the prevention of thromboembolic events in patients with atrial fibrillation: a systematic review of the clinical evidence.
出版信息
CADTH Technol Overv. 2012;2(3):e2304. Epub 2012 Sep 1.
Abstract
摘要
相似文献
1
Optimal warfarin management for the prevention of thromboembolic events in patients with atrial fibrillation: a systematic review of the clinical evidence.
CADTH Technol Overv. 2012;2(3):e2304. Epub 2012 Sep 1.
2
Efficacy and safety of traditional Chinese medicine on thromboembolic events in patients with atrial fibrillation: A systematic review and meta-analysis.
Complement Ther Med. 2017 Jun;32:1-10. doi: 10.1016/j.ctim.2017.03.006. Epub 2017 Mar 19.
3
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
J Am Coll Cardiol. 2014 Mar 25;63(11):1082-7. doi: 10.1016/j.jacc.2013.09.062. Epub 2013 Nov 6.
4
Indobufen: an updated review of its use in the management of atherothrombosis.
Drugs Aging. 2001;18(5):369-88. doi: 10.2165/00002512-200118050-00007.
5
Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
Arch Intern Med. 1995 May 8;155(9):913-20.
6
Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
Lancet. 1994 Mar 19;343(8899):687-91.
7
Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
Circulation. 2014 Jun 24;129(25):2638-44. doi: 10.1161/CIRCULATIONAHA.113.006426. Epub 2014 Apr 17.
8
Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Stroke. 2018 Jan;49(1):98-106. doi: 10.1161/STROKEAHA.117.018395. Epub 2017 Nov 22.
9
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Circulation. 2015 Aug 25;132(8):624-32. doi: 10.1161/CIRCULATIONAHA.114.014807. Epub 2015 Jun 23.
10
Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
Int J Cardiol. 2004 Jul;96(1):89-95. doi: 10.1016/j.ijcard.2003.06.014.
本文引用的文献
1
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007.
2
Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis.
J Am Coll Cardiol. 2010 Sep 7;56(11):827-37. doi: 10.1016/j.jacc.2010.05.028.
3
Underuse of oral anticoagulants in atrial fibrillation: a systematic review.
Am J Med. 2010 Jul;123(7):638-645.e4. doi: 10.1016/j.amjmed.2009.11.025.
4
Thromboembolism in atrial fibrillation.
Am J Cardiol. 2010 Feb 15;105(4):502-10. doi: 10.1016/j.amjcard.2009.10.018.
5
Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?
Curr Opin Neurol. 2010 Feb;23(1):65-72. doi: 10.1097/WCO.0b013e328334e67b.
6
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest. 2008 Jun;133(6 Suppl):160S-198S. doi: 10.1378/chest.08-0670.
7
Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
Ann Med. 2007;39(5):371-91. doi: 10.1080/07853890701320662.
8
Outpatient management of anticoagulation therapy.
Am Fam Physician. 2007 Apr 1;75(7):1031-42.
9
The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
J Clin Pharm Ther. 2007 Feb;32(1):21-9. doi: 10.1111/j.1365-2710.2007.00792.x.
10
Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).
J Thromb Thrombolysis. 2007 Apr;23(2):83-91. doi: 10.1007/s11239-006-9022-7.
Zotero 插件